2020plus
2020plus classifies genes as oncogenes, tumor suppressor genes, or non-driver genes using small somatic variant data and a Random Forest machine learning framework.
Key Features:
- Random Forest Classification: Applies a Random Forest ensemble learning algorithm to analyze somatic mutation data for driver gene prediction.
- Ratiometric Machine Learning Approach: Uses a machine-learning-based ratiometric strategy to improve classification accuracy of cancer driver genes.
- Driver Gene Categorization: Distinguishes oncogenes, tumor suppressor genes, and non-driver genes based on patterns of small somatic variants.
- Performance Evaluation Framework: Operates within a benchmarking framework that evaluates driver gene prediction methods and compares multiple computational approaches.
- Mutation Rate Variability Analysis: Examines the impact of unexplained variability in mutation rates on false-positive driver gene predictions.
Scientific Applications:
- Cancer Genomics: Supports identification and classification of cancer driver genes involved in tumorigenesis.
- Somatic Mutation Analysis: Enables analysis of somatic mutation datasets to evaluate gene roles in cancer development.
- Method Evaluation in Driver Gene Prediction: Facilitates comparison and benchmarking of computational approaches for cancer driver gene identification.
Methodology:
The tool applies a Random Forest machine learning model with a ratiometric feature-based approach to analyze somatic mutation data and classify genes into oncogenes, tumor suppressor genes, or non-driver genes while evaluating prediction performance across computational methods.
Topics
Details
- License:
- Apache-2.0
- Maturity:
- Mature
- Cost:
- Free of charge
- Tool Type:
- command-line tool, workflow
- Operating Systems:
- Linux
- Programming Languages:
- Python
- Added:
- 2/8/2019
- Last Updated:
- 11/25/2024
Operations
Data Inputs & Outputs
Expression profile clustering
Inputs
Outputs
Publications
Tokheim CJ, Papadopoulos N, Kinzler KW, Vogelstein B, Karchin R. Evaluating the evaluation of cancer driver genes. Proceedings of the National Academy of Sciences. 2016;113(50):14330-14335. doi:10.1073/pnas.1616440113. PMID:27911828. PMCID:PMC5167163.
PMID: 27911828
PMCID: PMC5167163
Funding: - HHS | NIH | National Cancer Institute: 1U24CA204817-01, 5U01CA180956-03, F31CA200266, P50-CA62924
Documentation
Downloads
- Source codehttps://github.com/KarchinLab/2020plus